Neuropeptide Y and alcoholism: Genetic, molecular, and pharmacological evidence

50Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.
Get full text

Abstract

This article presents the proceedings of a symposium presented at the combined meeting of the Research Society on Alcoholism and the International Society for Biomedical Research on Alcoholism, held in San Francisco, CA, in June 2002. The organizers and chairpersons were Subhash C. Pandey and Todd E. Thiele. The presentations were (1) Altered ethanol-induced sedation and ethanol drinking in mutant mice lacking specific NPY receptor, by Todd E. Thiele; (2) NPY in P and NP rats: polymorphism and mRNA expression, by Lucinda G. Carr; (3) The cAMP-dependent PKA in the central amygdala regulates alcohol intake through NPY gene, by Subhash C. Pandey; (4) Involvement of NPY in alcohol dependence: from animal models to human genetics, by Markus Heilig; and (5) Association of neuropeptide Y polymorphism with the occurrence of type 1 and type 2 alcoholism, by Erkki Ilveskoski.

Cite

CITATION STYLE

APA

Pandey, S. C., Carr, L. G., Heilig, M., Ilveskoski, E., & Thiele, T. E. (2003). Neuropeptide Y and alcoholism: Genetic, molecular, and pharmacological evidence. In Alcoholism: Clinical and Experimental Research (Vol. 27, pp. 149–154). https://doi.org/10.1097/01.ALC.0000052706.21367.0E

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free